Real-time enrollment status for this digestive system neuroendocrine tumor g1 clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:31 PM UTC
| NCT Number | NCT06016855 |
| Recruiting Status | Recruiting |
| Condition | Digestive System Neuroendocrine Tumor G1 |
| Phase | PHASE4 |
| Target Enrollment | 6 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vanderbilt-Ingram Cancer Center |
| Last Updated on CT.gov | June 24, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT06016855 is currently recruiting participants. This phase4 study for digestive system neuroendocrine tumor g1 is actively seeking new participants at 1 location across the United States. The study is sponsored by Vanderbilt-Ingram Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06016855 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06016855 was last updated 3 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.